NHTC Fundamental Analysis - NATURAL HEALTH TRENDS CORP

Fundamental Rating

Overall NHTC gets a fundamental rating of 3 out of 10. We evaluated NHTC against 36 industry peers in the Personal Care Products industry. No worries on liquidiy or solvency for NHTC as it has an excellent financial health rating, but there are worries on the profitability. NHTC has a expensive valuation and it also scores bad on growth. Finally NHTC also has an excellent dividend rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NHTC was profitable.

In the past year NHTC has reported a negative cash flow from operations.

NHTC had positive earnings in each of the past 5 years.

In multiple years NHTC reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.77%, NHTC is in line with its industry, outperforming 50.00% of the companies in the same industry.

NHTC has a Return On Equity of 1.21%. This is comparable to the rest of the industry: NHTC outperforms 58.33% of its industry peers.

		Industry Rank	Sector Rank
ROA	0.77%
ROE	1.21%
ROIC	N/A

ROA(3y)0.74%

ROA(5y)0.82%

ROE(3y)1.23%

ROE(5y)1.35%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NHTC has a Profit Margin of 0.83%. This is comparable to the rest of the industry: NHTC outperforms 52.78% of its industry peers.

NHTC's Profit Margin has declined in the last couple of years.

Looking at the Gross Margin, with a value of 73.97%, NHTC belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.

In the last couple of years the Gross Margin of NHTC has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	0.83%
GM	73.97%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-10.12%

PM growth 5YN/A

GM growth 3Y-0.45%

GM growth 5Y-0.03%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NHTC does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, NHTC has about the same amount of shares outstanding.

NHTC has more shares outstanding than it did 5 years ago.

NHTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.41 indicates that NHTC is not a great score, but indicates only limited risk for bankruptcy at the moment.

NHTC's Altman-Z score of 2.41 is in line compared to the rest of the industry. NHTC outperforms 52.78% of its industry peers.

There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	2.41

ROIC/WACCN/A

WACC8.77%

2.3 Liquidity

NHTC has a Current Ratio of 2.73. This indicates that NHTC is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of NHTC (2.73) is better than 66.67% of its industry peers.

A Quick Ratio of 2.55 indicates that NHTC has no problem at all paying its short term obligations.

The Quick ratio of NHTC (2.55) is better than 77.78% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.73
Quick Ratio	2.55

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NHTC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.67%.

Measured over the past years, NHTC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.90% on average per year.

NHTC shows a decrease in Revenue. In the last year, the revenue decreased by -2.08%.

NHTC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.15% yearly.

EPS 1Y (TTM)-66.67%

EPS 3Y-17.9%

EPS 5YN/A

EPS Q2Q%-100%

Revenue 1Y (TTM)-2.08%

Revenue growth 3Y-10.54%

Revenue growth 5Y-11.15%

Sales Q2Q%-6.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NHTC is valuated quite expensively with a Price/Earnings ratio of 145.17.

The rest of the industry has a similar Price/Earnings ratio as NHTC.

NHTC is valuated expensively when we compare the Price/Earnings ratio to 27.70, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	145.17
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 18.56%, NHTC is a good candidate for dividend investing.

NHTC's Dividend Yield is rather good when compared to the industry average which is at 5.83. NHTC pays more dividend than 100.00% of the companies in the same industry.

NHTC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.

		Industry Rank	Sector Rank
Dividend Yield	18.56%

5.2 History

The dividend of NHTC has a limited annual growth rate of 4.44%.

NHTC has paid a dividend for at least 10 years, which is a reliable track record.

NHTC has not decreased their dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)4.44%

Div Incr Years0

Div Non Decr Years10

5.3 Sustainability

NHTC pays out 2647.41% of its income as dividend. This is not a sustainable payout ratio.

DP2647.41%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NATURAL HEALTH TRENDS CORP

NASDAQ:NHTC (10/9/2025, 9:30:31 PM)

4.355

+0.04 (+0.95%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryPersonal Care Products

Earnings (Last)07-30 2025-07-30/bmo

Earnings (Next)10-29 2025-10-29

Inst Owners15.96%

Inst Owner Change0%

Ins Owners15.6%

Ins Owner Change0%

Market Cap50.13M

Analysts0

Price TargetN/A

Short Float %0.51%

Short Ratio1.26

Dividend

		Industry Rank	Sector Rank
Dividend Yield	18.56%

Yearly Dividend0.8

Dividend Growth(5Y)4.44%

DP2647.41%

Div Incr Years0

Div Non Decr Years10

Ex-Date08-12 2025-08-12 (0.2)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	145.17
Fwd PE	N/A
P/S	1.19
P/FCF	N/A
P/OCF	N/A
P/B	1.74
P/tB	1.74
EV/EBITDA	N/A

EPS(TTM)0.03

EY0.69%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.48

FCFYN/A

OCF(TTM)-0.48

OCFYN/A

SpS3.66

BVpS2.51

TBVpS2.51

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	0.77%
ROE	1.21%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	0.83%
GM	73.97%
FCFM	N/A

ROA(3y)0.74%

ROA(5y)0.82%

ROE(3y)1.23%

ROE(5y)1.35%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-10.12%

PM growth 5YN/A

GM growth 3Y-0.45%

GM growth 5Y-0.03%

F-Score4

Asset Turnover0.93

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	38.84%
Cap/Sales	0.11%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.73
Quick Ratio	2.55
Altman-Z	2.41

F-Score4

WACC8.77%

ROIC/WACCN/A

Cap/Depr(3y)47.19%

Cap/Depr(5y)53.89%

Cap/Sales(3y)0.17%

Cap/Sales(5y)0.25%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-66.67%

EPS 3Y-17.9%

EPS 5YN/A

EPS Q2Q%-100%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-2.08%

Revenue growth 3Y-10.54%

Revenue growth 5Y-11.15%

Sales Q2Q%-6.39%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-21.06%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-16.51%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-17.25%

OCF growth 3YN/A

OCF growth 5YN/A

NATURAL HEALTH TRENDS CORP (NHTC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens